MedPath

Quinapril

Generic Name
Quinapril
Brand Names
Accupril, Accuretic
Drug Type
Small Molecule
Chemical Formula
C25H30N2O5
CAS Number
85441-61-8
Unique Ingredient Identifier
RJ84Y44811

Overview

Quinapril is the ethyl ester prodrug of the non-sulfhydryl angiotensin converting enzyme inhibitor quinaprilat. It is used to treat hypertension and heart failure. ACE inhibitors are commonly used as a first line therapy in the treatment of hypertension, along with thiazide diuretics or beta blockers. Quinapril was granted FDA approval on 19 November 1991. A combination tablet with hydrochlorothiazide was also approved on 28 December 1999.

Indication

Quinapril is indicated for the treatment of hypertension and as an adjunct therapy in the treatment of heart failure. Quinapril in combination with hydrochlorothiazide is indicated for the treatment of hypertension.

Associated Conditions

  • Congestive Heart Failure (CHF)
  • Diabetic Nephropathy
  • Hypertension
  • Left Ventricular Dysfunction

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2023/02/06
Phase 4
Completed
2017/01/26
Phase 4
Completed
2009/06/30
N/A
Completed
2008/11/21
Not Applicable
Completed
2008/04/02
Phase 4
Completed
2008/04/01
Phase 1
Completed
2008/04/01
Phase 1
Completed
2008/04/01
Phase 1
Completed
2008/04/01
Phase 1
Completed
2006/04/12
Phase 4
Terminated
Montreal Heart Institute

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Carilion Materials Management
68151-1021
ORAL
10 mg in 1 1
6/13/2014
Carilion Materials Management
68151-1020
ORAL
5 mg in 1 1
6/13/2014
Carilion Materials Management
68151-1022
ORAL
20 mg in 1 1
6/13/2014

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Quinapril Hydrochloride Tablets
国药准字H19990330
化学药品
片剂(薄膜衣)
6/29/2020

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.